Tonix Pharmaceuticals Holding TNXP
NASDAQ TNXP
$8.91 -0.32 (-3.47%)
At close: Oct 2, 2026 · 4:00 PM EDT

Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed [ROCE] (2012 - 2026)

Updated

Tonix Pharmaceuticals Holding (TNXP) posted Return on Capital Employed [ROCE] of -73.45% for Q2 2026, down 25.29 percentage points from -48.16% a year earlier and down 9.90 percentage points from the prior quarter.

Analysis

Tonix Pharmaceuticals Holding (TNXP) Return on Capital Employed [ROCE] (2012 - 2026) Analysis & Trends

For FY2025, Tonix Pharmaceuticals Holding's Return on Capital Employed [ROCE] came in at -66.44%, up 30.95 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] shows a five-year change of +42.06 percentage points (FY2020 to FY2025).
  • In prior years, Tonix Pharmaceuticals Holding's Return on Capital Employed [ROCE] was -97.39% in FY2024 (-28.24 pp), -69.15% in FY2023 (-17.04 pp), -52.11% in FY2022 (+10.34 pp) and -62.45% in FY2021 (+46.06 pp).
  • The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q1 2025.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in five of the last eight quarters, with an average year-over-year change of +27.67 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q3 2025, with a gain of 159.57 percentage points; the weakest was Q3 2024, with a drop of 115.87 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -63.55% (Q1 2026), -53.73% (Q4 2025) and -50.23% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 17.83%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 17.92%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 6.28%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 19.32%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 9.54%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 16.66%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -5.97%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.86%
10 Tonix Pharmaceuticals Holding 149.62 Mn 149.62 Mn 12.84 Mn -73.45%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -73.45%
Mar 31, 2026 -63.55%
Dec 31, 2025 -53.73%
Sep 30, 2025 -50.23%
Jun 30, 2025 -48.16%
Mar 31, 2025 -79.29%
Dec 31, 2024 -123.56%
Sep 30, 2024 -209.81%
Jun 30, 2024 -190.81%
Mar 31, 2024 -85.06%
Dec 31, 2023 -92.49%
Sep 30, 2023 -93.93%
Jun 30, 2023 -82.95%
Mar 31, 2023 -63.15%
Dec 31, 2022 -51.90%
Sep 30, 2022 -44.23%
Jun 30, 2022 -41.78%
Mar 31, 2022 -45.18%
Dec 31, 2021 -44.79%
Sep 30, 2021 -42.04%
API Access

Tonix Pharmaceuticals Holding Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=TNXP&period=max&api_key=YOUR_API_KEY